Keyphrases
Randomized Trial
100%
Once-daily
100%
Acute Exacerbation of COPD (AECOPD)
100%
Tiotropium
100%
Inhaled Anticholinergics
100%
Anticholinergic Bronchodilators
100%
Healthcare Utilization
37%
Chronic Obstructive Pulmonary Disease
25%
Moderate to Severe
25%
Placebo
25%
Severe Chronic Obstructive Pulmonary Disease
25%
Antibiotic Treatment
12%
Health Systems
12%
Forced Expiratory Volume in 1 Second (FEV1)
12%
Hospitalization Rate
12%
Hospitalization
12%
Veterans Affairs Medical Center
12%
Statistical Significance
12%
Usual Care
12%
Clinic Visits
12%
Trial Participants
12%
All-cause Hospitalization
12%
Health Resource Use
12%
Clinical Resources
12%
Disease-related
12%
Randomized Double-blind Study
12%
Number of Hospitalization
12%
Nursing and Health Professions
Obstructive Lung Disease
100%
Bronchodilator
100%
Cholinergic Receptor Blocking Agent
100%
Disease Exacerbation
50%
Health Care Utilization
30%
Placebo
20%
Health Care Planning
10%
Healthcare System
10%
Antibiotic Therapy
10%
Forced Expiratory Volume
10%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Parasympatholytic
100%
Bronchodilating Agent
100%
Disease Exacerbation
50%
Health Care Utilization
30%
Placebo
20%
Health Care
10%
Veterans Affairs
10%
Forced Expiratory Volume
10%
Antibiotic Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Cholinergic Receptor Blocking Agent
100%
Bronchodilating Agent
100%
Disease Exacerbation
50%
Placebo
20%
Biochemistry, Genetics and Molecular Biology
Forced Expiratory Volume
100%